YEIDA Delegation Pitches Top MedTech Leaders on UP’s Medical Devices Park

Bengaluru, November 17, 2025: A high-level delegation from the Yamuna Expressway Industrial Development Authority (YEIDA), led by CEO Rakesh Kumar Singh, conducted investment meetings in Bengaluru, aiming to attract major manufacturers to the Medical Devices Park being developed under YEIDA in Uttar Pradesh.

The delegation, which included Shailendra Kumar Bhatia IAS (OSD, YEIDA/Nodal officer ) and Praveen Kumar Mittal (Executive Director, Export Promotion Council for Medical Devices – EPCMD), made a strong investment pitch to leading global healthcare technology companies, including Wipro GE Healthcare and Philips India, etc.

The YEIDA delegation’s primary objective was to showcase the strategic advantages and robust support system and multimodal connectivity available at the Medical Devices Park, UP.

Wipro GE Healthcare

The delegation met with Chaitanya Sarawate, President and CEO, South Asia, GE Healthcare. Singh’s presentation was well-received, opening discussions on various opportunities within the park. The delegation was given a detailed presentation on GE Healthcare’s long-standing partnership and growth in India and toured the GE Bell manufacturing facility to observe the production of X-ray tubes. The YEIDA team also requested GE Healthcare’s guidance on developing common scientific facilities at the park.

Philips Innovation Centre

The delegation visited the Philips Innovation Centre in Bangalore, meeting with Shri Arvind Vaishnav and Shri Harish. A comprehensive presentation on the YEIDA Medical Devices Park was shared, followed by a visit to the innovation lab. The delegation formally requested that Philips consider making investments in the UP park, a proposal that was noted by the Philips India office.

The delegation’s mission continues with a planned visit to Panacea Medical Technologies. The YEIDA delegation will meet with the leadership and tour their manufacturing plant to further discuss the advantages of establishing operations in the Medical Devices Park.

The YEIDA Medical Devices Park is a key government initiative aimed at bolstering domestic manufacturing, reducing import reliance, and positioning Uttar Pradesh as a central hub for medical technology innovation and export.

The Yamuna Expressway Industrial Development Authority (YEIDA) is the nodal agency responsible for the overall development of the Yamuna Expressway region in Uttar Pradesh, focusing on creating world-class infrastructure and promoting industrial growth, including specialized sectors like medical devices.

The Medical Device Park (MDP) developed by the Yamuna Expressway Industrial Development Authority (YEIDA), is being developed as India’s first fully-integrated MedTech hub with the vision of making India self-reliant in high-quality medical devices.

Key Investment Highlights

• Project Overview: Located in Sector 28, YEIDA Phase-I, the park covers 350 acres and is an approved Government of India (GoI) project with a total cost of INR 439.49 Crore (including a GoI Grant of INR 100 Crore).

• Progress and Traction: Infrastructure development is 90% complete, and approximately 50% of the land has been allotted. The park has successfully allotted 101 plots, securing INR 1,291 Crore in investment, with 10 allottees already starting construction.

• Strategic Location & Connectivity: The park is strategically located just 3 kms (3 minutes) from the Noida International Airport (NIAL), offering unmatched multi-modal connectivity via expressways, proposed rail links, and proximity to the entire NCR region.

• > Robust Ecosystem & Common Facilities: The park provides extensive support, including:

* Common Scientific Facilities (CSF): Planned facilities for Bio-Material Testing, Electronic Assembly, Rapid Prototyping & Testing Labs, and IOMT & AIML.

* Other Facilities: Central Warehouses, an Administrative Office Block, and a Center of Excellence.

* Attractive Incentive Regime: Investors benefit from a holistic incentive package, notably:

* Highly Subsidized Land Rates: Land is offered at heavily discounted rates, significantly below standard industrial pricing, with rates starting from INR 4,705/sqm (for plots above 80,001 sqm).

* Financial Incentives: 100% exemption on stamp duty, SGST reimbursement (70% for 10 years), and Capital Interest Subsidy (up to 7.5% interest reimbursement).

> Target Segments: The park is focusing on key segments:

*Radiology & Imaging medical devices (both ionizing & non-ionizing radiation products) and Nuclear

* In Vitro Diagnostic (IVD)

* Cancer care/ Radiotherapy medical devices

* All implants including Implantable electronic devices

* Anaesthetics & Cardio-respiratory medical devices including Catheters of Cardiorespiratory Category & Renal Care medical